title: Limitations to the use of the CA-125 antigen level in ovarian cancer.
authors.affiliation: Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, R35, 9500 Euclid Avenue, Cleveland, OH 44195, USA. markmam@ccf.org
authors.forename: Maurie
authors.initials: M
authors.lastname: Markman
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis / Q000097:blood*; D018394:CA-125 Antigen / Q000032:analysis / Q000097:blood*; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D011379:Prognosis; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D018394:CA-125 Antigen